| ELEMENT LIST | CURRENT QUARTER | SIMILAR QUARTER FOR PREVIOUS YEAR | %CHANGE | PREVIOUS QUARTER | % CHANGE |
|---|---|---|---|---|---|
| Sales/Revenue | 599,285,124 | 509,509,672 | 17.619 | 663,020,883 | -9.612 |
| Gross Profit (Loss) | 249,390,235 | 207,166,404 | 20.381 | 250,319,375 | -0.371 |
| Operational Profit (Loss) | 107,426,446 | 63,047,481 | 70.389 | 76,562,987 | 40.311 |
| Net Profit (Loss) after Zakat and Tax | 50,605,768 | 34,093,603 | 48.431 | 37,923,095 | 33.443 |
| Total Comprehensive Income | 38,024,819 | 23,640,777 | 60.844 | 47,116,591 | -19.296 |
| All figures are in (Actual) Saudi Arabia, Riyals |
| ELEMENT LIST | CURRENT PERIOD | SIMILAR PERIOD FOR PREVIOUS YEAR | %CHANGE |
|---|---|---|---|
| Total Share Holders Equity (after Deducting Minority Equity) | 1,363,871,382 | 1,238,922,186 | 10.085 |
| Profit (Loss) per Share | 0.63 | 0.43 | |
| All figures are in (Actual) Saudi Arabia, Riyals |
| ELEMENT LIST | EXPLANATION |
|---|---|
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit increases in general due to:1. Increase in sales in the following sectors:a. Specialty chemical sectorb. Power and steel sector2. Decrease in Selling and Distribution expenses in the following sectors:a. Pharmaceuticals sectorb. Power and steel sectorWhile noting that there is increase in other expenses and provision for impairment of financial assets expense. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the previous period of the current year is | Net profit increases in general due to:1. Decrease in Selling and Distribution expenses in Pharmaceuticals sector2. Decrease in provision for impairment for financial assets expense in the following sectors:a. Pharmaceuticals sectorb. Power and steel sector3. Decrease in Zakat and Income tax expenses in Pharmaceuticals sectorWhile noting that there is increase in other expenses. |
| Statement of the type of external auditor’s report | Unmodified conclusion |
| Reclassification of Comparison Items | No comparative figures for the previous period have been reclassified |
| Additional Information | 1. Net Shareholders’ Equity at the end of the period was SR1,421,009,316 /- compared to SR1,223,695,759/- at the end of the similar period last year with an increase of 16%. |
The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.